Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. Mai 2017 08:00 ET | Quelle: CytomX Therapeutics Inc.

CytomX to Present at the Jefferies 2017 Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 25, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment...
17. Mai 2017 08:00 ET | Quelle: CytomX Therapeutics Inc.

CytomX Announces Upcoming Poster Presentation at American Society for Clinical Oncology Annual Meeting

SOUTH SAN FRANCISCO, Calif., May 17, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment...
15. Mai 2017 16:01 ET | Quelle: CytomX Therapeutics Inc.

CytomX Announces Management Team Changes

SOUTH SAN FRANCISCO, Calif., May 15, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment...
05. Mai 2017 08:00 ET | Quelle: CytomX Therapeutics Inc.

CytomX Announces First Quarter 2017 Financial Results

SOUTH SAN FRANCISCO, Calif., May 05, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment...
27. April 2017 16:05 ET | Quelle: CytomX Therapeutics Inc.

CytomX Therapeutics to Announce First Quarter 2017 Financial Results

SOUTH SAN FRANCISCO, Calif., April 27, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the...
30. März 2017 08:00 ET | Quelle: CytomX Therapeutics Inc.

CytomX Therapeutics Appoints Marion McCourt to Board of Directors

SOUTH SAN FRANCISCO, Calif., March 30, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the...
19. März 2017 19:00 ET | Quelle: CytomX Therapeutics Inc.

CytomX Therapeutics Announces Teleconference and Webcast to Provide Corporate Update

SOUTH SAN FRANCISCO, Calif., March 19, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the...
02. März 2017 16:05 ET | Quelle: CytomX Therapeutics Inc.

CytomX Announces Full-Year 2016 Financial Results

SOUTH SAN FRANCISCO, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the...
01. März 2017 08:00 ET | Quelle: CytomX Therapeutics Inc.

CytomX Therapeutics to Announce Full-Year 2016 Financial Results

SOUTH SAN FRANCISCO, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the...
21. Februar 2017 16:05 ET | Quelle: CytomX Therapeutics Inc.

CytomX Therapeutics to Present at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment...

Vorherige Seite